James Hassard

CRNX

James Hassard serves as Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. (CRNX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$1.72M

Net Position

Net Seller

$1.72M

Companies Traded

CRNX, ARWR

Active Period

Jun 2021 – Jul 2024

4 total trades

Most Recent

Sell CRNX

Jul 5, 2024 · $661.2K

James Hassard's Insider Trading at Crinetics Pharmaceuticals, Inc. (CRNX)

Buys

0 · $0.00

Sells

3 · $1.40M

Total Shares Bought

Total Shares Sold

31,741

CRNX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Jul 5, 2024	Sell	15,000	$44.08	$661.2K
Jun 21, 2024	Sell	15,000	$44.66	$669.9K
Mar 18, 2024	Sell	1,741	$38.14	$66.4K

James Hassard's Insider Trading at Arrowhead Pharmaceuticals, Inc. (ARWR)

Buys

0 · $0.00

Sells

1 · $323.4K

Total Shares Bought

Total Shares Sold

3,625

ARWR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 22, 2021	Sell	3,625	$89.22	$323.4K	0

Related Insiders

James C Hamilton

officer: Chief Medical Officer

ARWRSell · Apr 24, 2026

Daniel Joseph Apel

officer: Chief Financial Officer

ARWRSell · Apr 24, 2026

Jeff E. Knight

officer: Chief Operating Officer

CRNXSell · Apr 10, 2026

Richard Scott Struthers

President & CEO

CRNXSell · Mar 18, 2026

Stephen F. Betz

officer: Chief Scientific Officer

CRNXSell · Mar 18, 2026

Coelho Rogerio Vivaldi

director

CRNXSell · Mar 13, 2026

Isabel Kalofonos

Chief Commercial Officer

CRNXSell · Jan 5, 2026

Christopher Richard Anzalone

Chief Executive Officer

ARWRSell · Jan 2, 2026

Explore More Insider Trading Data

CRNX Insider Trading Activity

View all insider trades at Crinetics Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity